IA2030 Action Plans and Impact Acceleration Reports: Survey responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle 2022)

Le résumé fourni par la source

# IA2030 Action Plans and Impact Acceleration Reports: Survey responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle 2022) Note: This document includes markdown syntax to facilitate machine reading. ## Table of Contents - Abstract - Research Audience - Credits - Recommended Citation - File List - Related Data Sets - Background - Data Set Structure and Contents - Data Cleaning, Data Privacy, and Anonymization - Ethical Considerations - Survey Implementation - Survey Questionnaire Items - Data Availability and Accessibility - Copyright and License - References ## Abstract The Immunization Agenda 2030 (IA2030) has been endorsed at the World Health Assembly as the world’s strategy for immunization. The Movement for IA2030 is a voluntary collective of immunization practitioners, principally from low- and middle-income countries, who have pledged to support each other to accelerate local action in support of this global immunization strategy. This data set offers insights into how to understand national and sub-national challenges facing immunization programmes and what strategies show promise for addressing these challenges over time. It contains: - raw, anonymized data in Excel CSV format. Copies of the three survey questionnaires are available for download in the Files section (below). - responses to one, two, or three surveys from 931 national and subnational immunization practitioners participating in the Movement for Immunization Agenda (IA) 2030: Survey 1: IA2030 Action Plan Survey: a 77-item questionnaire, fielded in May 2022, which asked respondents to identify a key challenge relevant to their immunization programme, root cause of the challenge, three corrective actions, and what they knew about vaccination coverage in their zone of intervention. Survey 2: IA2030 Impact Acceleration Report Survey (2022): a 27-item questionnaire, fielded in June 2022, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators. Survey 3: IA2030 Impact Acceleration Report Survey (2023): a 60-item questionnaire, fielded in June 2023, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators. ## Research Audience Education and global health researchers with interest in human resources for health (HRH) and the characteristics, priority challenges, and experiences of national and sub-national immunization staff participating in the Movement for Immunization Agenda (IA) 2030. ## Credits ### Author The Geneva Learning Foundation (TGLF) 18 Avenue Louis Casaï CH1209 Geneva, Switzerland research@learning.foundation Principal Investigator and Corresponding Author Reda Sadki, TGLF reda@learning.foundation Project Partners - Biostat Global Consulting (BGC) - Bridges to Development - Centre for Change & Complexity in Learning (C3L) Partner Roles and Responsibilities - Design: TGLF - Implementation (sample collection): TGLF - Processing: TGLF, C3L - Anonymization: BGC - Submission: TGLF - Maintenance of learning analytics database where data are stored: C3L Funding Wellcome Trust, Bill & Melinda Gates Foundation (BMGF) ## Recommended Citation Action Plans and Impact Acceleration Reports: Responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle). The Geneva Learning Foundation, 2023. (Version 1.0) [Data Set]. The Geneval Learning Foundation. https://doi.org/10.5281/zenodo.8298773 ## File List 2023-09.IA2030_Action_Plans_and_Impact_Acceleration_Reports.README.md (this document) 2022-05.IA2030_Action_Plan_Survey.docx: List of items included in the Action Plan Survey 2022-06.IA2030_Impact_Acceleration_Report_Survey.docx: List of items included in the Impact Acceleration Report Survey questionnaire administered in June 2022. 2023-06.IA2030_Impact_Acceleration_Report_Survey.docx: List of additional items included in the Impact Acceleration Survey administered in June 2023 (the complete survey questionnaire also included all items included in the June 2022 Impact Acceleration Report Survey questionnaire). 2023-09.IA2030_Action_Plans_and_Impact_Acceleration_Reports_Survey_Dataset.csv: Anonymized Action Plans and Acceleration Reports Survey Dataset. Version 1: Geneva Learning Foundation (937 observations, 173 variables). ## Related Data Sets The 2023-09.IA2030_Action_Plans_and_Impact Acceleration_Reports_Survey_Dataset.csv is a subset of data collected by The Geneva Learning Foundation (TGLF) during the first IA2030 Full Learning Cycle (FLC) during May 2022, June 2022, and June 2023. The complete IA 2030 Action Plans and Impact Acceleration Reports Survey data set is more comprehensive and includes information about respondent and programme characteristics as well as responses to open-text questions. Researchers who would like to analyze the full set of unredacted responses are invited to contact the Geneva Learning Foundation to inquire about a data sharing agreement that would stipulate conditions of access (insights@learning.foundation). The Geneva Learning Foundation, 2023. Value Creation Stories (VCS) weekly feedback survey, 2022 Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) (Version 1.0). [Data Set]. The Geneva Learning Foundation. https://doi.org/10.5281/zenodo.7763922 The Geneva Learning Foundation, 2023. Full Learning Cycle (2022) Application for national and sub-national immunization staff to identify challenges and join the Movement for Immunization Agenda (IA 2030) (Version 1.0) [Data Set]. The Geneval Learning Foundation. https://doi.org/10.5281/zenodo.8199552 Additional data sets for the first Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) are available from TGLF’s Insights Unit (insights@learning.foundation). ## Background The Immunization Agenda 2030 (IA2030), the global immunization strategy for 2021-2030, set ambitious targets for global immunization coverage and other key indicators (World Health Organization [WHO], 2020). In response to the WHO Director-General’s call for a social movement to ensure immunization remains a priority for global and regional health agendas and promote broad societal support for immunization (WHO, 2020), TGLF, working with its global community of over 35,000 alumni, developed a learning programme intended to contribute to a “Movement for Immunization Agenda 2030.” As part of their participation in the programme, IA2030 participants developed a locally tailored action plan designed to address a key challenge relevant to their immunization programme. A project kick-off phase, the “Impact Accelerator Launch Pad”, supported participants during their initial implementation stages, to create momentum for sustained action. One month after initiation of their Action Plan(s), participants were invited to complete an Impact Acceleration survey questionnaire to assess progress towards their goals. One year later, programme participants were invited to complete a second Impact Acceleration questionnaire to assess continued progress towards their goal. This data set includes participants’ responses to one or more questionnaires documenting their IA2030 experience: - Survey 1: IA2030 Action Plan Survey: a 77-item questionnaire, fielded in May 2022, which asked respondents to identify a key challenge relevant to their immunization programme, root cause of the challenge, three corrective actions, and what they knew about vaccination coverage in their zone of intervention. - Survey 2: IA2030 Impact Acceleration Report Survey (2022): a 27-item questionnaire, fielded in June 2022, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators. - Survey 3: IA2030 Impact Acceleration Report Survey (2023): a 60-item questionnaire, fielded in June 2023, which asked re

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.